Showing 17,961 - 17,980 results of 77,880 for search '(( a e decrease ) OR ( 50 ((((teer decrease) OR (mean decrease))) OR (a decrease)) ))', query time: 1.31s Refine Results
  1. 17961
  2. 17962
  3. 17963
  4. 17964
  5. 17965
  6. 17966

    Impaired differentiation of alveolar epithelial type I cells in E18.5 <i>Snx5<sup>-/-</sup></i> lungs. by Sun-Kyoung Im (36750)

    Published 2013
    “…The nuclei were stained with Hoechst. Scale bars: 50 µm. (B) Decreased protein expression of T1α in E18.5 (n  =  4). …”
  7. 17967
  8. 17968

    Ginsenoside Rd inhibits migration and invasion of tongue cancer cells through H19/miR-675-5p/CDH1 axis by Lu CHANG (13639620)

    Published 2022
    “…H19 and miR-675-5p expressions decreased after ginsenoside Rd treatment, while CDH1 and E-cadherin expressions increased. …”
  9. 17969

    Protein identification list. by Yang Zhang (30734)

    Published 2024
    “…After MEL treatment, the expression of collagen III and α-SMA decreased, the expression of E-cadherin increased, and the expression of vimentin and N-cadherin also decreased. …”
  10. 17970
  11. 17971

    The Base-Editing Enzyme APOBEC3A Catalyzes Cytosine Deamination in RNA with Low Proficiency and High Selectivity by Aleksia Barka (12218135)

    Published 2022
    “…Altogether, our work reveals a relationship between the overall decreased reactivity of A3A and increased substrate selectivity, and our results hold implications both for characterizing off-target mutagenesis and for engineering optimized DNA deaminases for base-editing technologies.…”
  12. 17972

    Table_1_Family psychoeducation to improve outcome in caregivers and patients with schizophrenia: a randomized clinical trial.docx by Arnaud Tessier (1734355)

    Published 2023
    “…</p>Results<p>On the 25 patients included, the mean age was 33.3 years (SD = 9.7) with a mean duration of disease of 7.48 years (SD = 7.1). …”
  13. 17973

    Table_6_Exploring the multifaceted therapeutic mechanism of Schisanlactone E (XTS) in APP/PS1 mouse model of Alzheimer’s disease through multi-omics analysis.XLSX by Zhenyan Song (17434881)

    Published 2024
    “…Background<p>Schisanlactone E, also known as XueTongSu (XTS), is an active compound extracted from the traditional Tujia medicine Kadsura heteroclita (“XueTong”). …”
  14. 17974

    Table_7_Exploring the multifaceted therapeutic mechanism of Schisanlactone E (XTS) in APP/PS1 mouse model of Alzheimer’s disease through multi-omics analysis.XLSX by Zhenyan Song (17434881)

    Published 2024
    “…Background<p>Schisanlactone E, also known as XueTongSu (XTS), is an active compound extracted from the traditional Tujia medicine Kadsura heteroclita (“XueTong”). …”
  15. 17975

    Table_1_Exploring the multifaceted therapeutic mechanism of Schisanlactone E (XTS) in APP/PS1 mouse model of Alzheimer’s disease through multi-omics analysis.XLSX by Zhenyan Song (17434881)

    Published 2024
    “…Background<p>Schisanlactone E, also known as XueTongSu (XTS), is an active compound extracted from the traditional Tujia medicine Kadsura heteroclita (“XueTong”). …”
  16. 17976

    Table_5_Exploring the multifaceted therapeutic mechanism of Schisanlactone E (XTS) in APP/PS1 mouse model of Alzheimer’s disease through multi-omics analysis.XLSX by Zhenyan Song (17434881)

    Published 2024
    “…Background<p>Schisanlactone E, also known as XueTongSu (XTS), is an active compound extracted from the traditional Tujia medicine Kadsura heteroclita (“XueTong”). …”
  17. 17977

    Table_3_Exploring the multifaceted therapeutic mechanism of Schisanlactone E (XTS) in APP/PS1 mouse model of Alzheimer’s disease through multi-omics analysis.XLSX by Zhenyan Song (17434881)

    Published 2024
    “…Background<p>Schisanlactone E, also known as XueTongSu (XTS), is an active compound extracted from the traditional Tujia medicine Kadsura heteroclita (“XueTong”). …”
  18. 17978

    Table_2_Exploring the multifaceted therapeutic mechanism of Schisanlactone E (XTS) in APP/PS1 mouse model of Alzheimer’s disease through multi-omics analysis.DOCX by Zhenyan Song (17434881)

    Published 2024
    “…Background<p>Schisanlactone E, also known as XueTongSu (XTS), is an active compound extracted from the traditional Tujia medicine Kadsura heteroclita (“XueTong”). …”
  19. 17979

    Table_4_Exploring the multifaceted therapeutic mechanism of Schisanlactone E (XTS) in APP/PS1 mouse model of Alzheimer’s disease through multi-omics analysis.XLSX by Zhenyan Song (17434881)

    Published 2024
    “…Background<p>Schisanlactone E, also known as XueTongSu (XTS), is an active compound extracted from the traditional Tujia medicine Kadsura heteroclita (“XueTong”). …”
  20. 17980